VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202 | -10.6% | 7,500 | 0.0% | 0.01% | -40.0% |
| Q2 2023 | $226 | -7.0% | 7,500 | 0.0% | 0.01% | -9.1% |
| Q1 2023 | $243 | +41.3% | 7,500 | +25.0% | 0.01% | +37.5% |
| Q4 2022 | $172 | -99.9% | 6,000 | 0.0% | 0.01% | +60.0% |
| Q3 2022 | $145,000 | -11.6% | 6,000 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $164,000 | +113.0% | 6,000 | +200.0% | 0.01% | +100.0% |
| Q1 2022 | $77,000 | +20.3% | 2,000 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $64,000 | +120.7% | 2,000 | +100.0% | 0.00% | +100.0% |
| Q3 2021 | $29,000 | -14.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $34,000 | -63.8% | 1,000 | -65.5% | 0.00% | -75.0% |
| Q1 2021 | $94,000 | -85.8% | 2,900 | -84.2% | 0.00% | -87.5% |
| Q4 2020 | $660,000 | +396.2% | 18,300 | +438.2% | 0.03% | +357.1% |
| Q3 2020 | $133,000 | – | 3,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |